Why the study?
Doxorubicin-induced cardiomyopathy is a common chemotherapy complication causing cardiac remodeling and reduced function, with unclear potential for treatment via intrapericardial hydrogel delivery of stromal cells and secretome.
Does intrapericardial injection of dECM hydrogels loaded with ASC and their secretome improve heart function in a rat model of doxorubicin-induced cardiomyopathy?
Does intrapericardial injection of dECM hydrogels loaded with ASC and their secretome improve heart function in a rat model of doxorubicin-induced cardiomyopathy?
Intrapericardial injection of dECM hydrogels loaded with ASC and their secretome improves ventricular hemodynamics and reduces cardiac remodeling in a rat model of doxorubicin-induced cardiomyopathy.
May support dECM-ASC hydrogel therapy in rat DOX-IC models; leaves open translation to clinical chemotherapy patients.
Doxorubicin-induced cardiomyopathy (DOX-IC) is a significant and common complication in patients undergoing chemotherapy, leading to cardiac remodeling and reduced heart function. We hypothesized that the intrapericardial injection of hydrogels derived from the cardiac decellularized extracellular matrix (dECM) loaded with adipose tissue-derived stromal cells (ASC) and their secretome dampens or reverses the progression of DOX-IC. DOX-IC was induced in Wistar male rats through ten weekly intra-peritoneal injections of doxorubicin (cumulative dose: 18 mg/kg). We performed intrapericardial treatment in week five with dECM hydrogel loaded with ASC and their conditioned medium (CMed). The volume of intrapericardial injection was 2 ml/kg, the ASC density was 20 million/mL, while the hydrogel contained 100-fold concentrated CMed. Interstitial myocardial fibrosis was assessed by PicroSirius Red staining and hemodynamics parameters in pressure-volume loops. Compared to saline controls, interstitial myocardial fibrosis was reduced in ASC/CMed-loaded hydrogels treated animals (p = 0.0139). Ejection fraction and cardiac work efficiency improved in the ASC/CMed-treated rats compared to saline treatment (p = 0.0151 and p = 0.0655, respectively). The intrapericardial injection of dECM hydrogels loaded with ASC and their secretome warrants a novel therapeutic modality to improve ventricular hemodynamics and reduce cardiac remodeling in DOX-IC.
No takes yet. Share an insight, caveat, or question.
Liguori et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: